CDKN1B and acute myeloid leukemia: Also, lncRNA UCA1 could be an oncogene by inhibiting the expression of p27kip1 from maintaining the proliferation of AML cells, suggesting that lncRNA UCA1 could be a novel diagnostic biomarker and a potential therapeutic target for AML in AML with CEBPA mutation (Hughes et al., 2015).